Raleigh Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.2K | Buy |
51
+3
| +6% | +$775 | 0.01% | 355 |
|
|
2025
Q1 | $10.8K | Sell |
48
-85
| -64% | -$19.1K | ﹤0.01% | 356 |
|
|
2024
Q4 | $30.4K | Sell |
133
-19
| -13% | -$4.35K | 0.01% | 387 |
|
|
2024
Q3 | $37.1K | Buy |
152
+19
| +14% | +$4.64K | 0.01% | 356 |
|
|
2024
Q2 | $25.5K | Buy |
133
+32
| +32% | +$6.13K | 0.01% | 395 |
|
|
2024
Q1 | $20K | Sell |
101
-74
| -42% | -$14.7K | 0.01% | 423 |
|
|
2023
Q4 | $30.2K | Buy |
175
+3
| +2% | +$518 | 0.01% | 358 |
|
|
2023
Q3 | $25.5K | Buy |
172
+28
| +19% | +$4.15K | 0.01% | 359 |
|
|
2023
Q2 | $31.5K | Buy |
+144
| New | +$31.5K | 0.02% | 300 |
|